PACBODY
LIVE

Serial Number

88658020

Owner

Phanes Therapeutics,Inc.

Attorney

Matthew R. Grothouse

Filing Date

Oct 17, 2019

Add to watchlist:

No watchlists yet
View on USPTO

PACBODY Trademark

Serial Number: 88658020 • Registration: 7080972

PACBODY is a trademark filed by Phanes Therapeutics,Inc. on October 17, 2019. The trademark is classified under Class 42 (Computer & Scientific). The application is currently registered and active.

Owner Contact Info

Phanes Therapeutics,Inc. (12 trademarks)

9215 BROWN DEER ROAD, SUITE B
SAN DIEGO, CA 92121

Entity Type: 03

Trademark Details

Filing Date

October 17, 2019

Registration Date

June 13, 2023

First Use in Commerce

March 16, 2023

Published for Opposition

June 9, 2020

Goods & Services

Scientific and technological services and research and development activities relating thereto, namely, antibody research and design; Providing recombinant antibody technology platform in the nature of research and development of monospecific, bispecific and multi-specific antibodies or fragments and the development of pharmaceutical products based on monospecific, bispecific and multi-specific antibodies or fragments; Research and development services in the field of antibodies; research and development of pharmaceuticals for the treatment of age-related diseases and cancer; medical and scientific research in the field of cancer treatment and diagnosis; technical research in the field of pharmaceutical studies; research on the subject of pharmaceuticals; research and development in the pharmaceutical and biotechnology fields; pharmaceutical research and development; pharmaceutical product development; product developability testing, namely, pharmaceutical antibody evaluation; development of pharmaceutical preparations and medicines; product design-based functionality testing, namely, conducting early evaluations in the field of new pharmaceuticals; medical and scientific research, namely, conducting clinical trials for others; chemical, biochemical, biological and bacteriological research and analysis; biological research; scientific study, research and development in the fields of medicine, the prevention, treatment and management of illness, health care delivery; technology research in the field of pharmaceutical research and development; medical research; medical laboratories

Filing History

NOTICE OF REGISTRATION CONFIRMATION EMAILED
Jun 13, 2023 NRCC
REGISTERED-PRINCIPAL REGISTER
Jun 13, 2023 R.PR
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
May 11, 2023 SUNA
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
May 10, 2023 CNPR
STATEMENT OF USE PROCESSING COMPLETE
Apr 7, 2023 SUPC
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Apr 6, 2023 AITU
USE AMENDMENT FILED
Mar 21, 2023 IUAF
TEAS STATEMENT OF USE RECEIVED
Mar 21, 2023 EISU
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Aug 26, 2022 EXRA
SOU EXTENSION 4 GRANTED
Aug 24, 2022 EX4G
SOU EXTENSION 4 FILED
Aug 24, 2022 EXT4
SOU TEAS EXTENSION RECEIVED
Aug 24, 2022 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Mar 30, 2022 EXRA
SOU EXTENSION 3 GRANTED
Mar 28, 2022 EX3G
SOU EXTENSION 3 FILED
Mar 28, 2022 EXT3
SOU TEAS EXTENSION RECEIVED
Mar 28, 2022 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jul 13, 2021 EXRA
SOU EXTENSION 2 GRANTED
Jul 9, 2021 EX2G
SOU EXTENSION 2 FILED
Jul 9, 2021 EXT2
SOU TEAS EXTENSION RECEIVED
Jul 9, 2021 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Mar 3, 2021 EXRA
SOU EXTENSION 1 GRANTED
Mar 1, 2021 EX1G
SOU EXTENSION 1 FILED
Mar 1, 2021 EXT1
SOU TEAS EXTENSION RECEIVED
Mar 1, 2021 EEXT
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Feb 23, 2021 TCCA
TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Feb 23, 2021 EWAF
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Feb 23, 2021 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Feb 23, 2021 REAP
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Sep 29, 2020 NOAM
EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED
Aug 19, 2020 ETOP
EXTENSION OF TIME TO OPPOSE RECEIVED
Jul 8, 2020 ETOF
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jun 9, 2020 NPUB
PUBLISHED FOR OPPOSITION
Jun 9, 2020 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
May 20, 2020 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Apr 30, 2020 CNSA
EXAMINER'S AMENDMENT ENTERED
Apr 30, 2020 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Apr 30, 2020 GNEN
EXAMINERS AMENDMENT E-MAILED
Apr 30, 2020 GNEA
EXAMINERS AMENDMENT -WRITTEN
Apr 30, 2020 CNEA
NOTIFICATION OF FINAL REFUSAL EMAILED
Apr 14, 2020 GNFN
FINAL REFUSAL E-MAILED
Apr 14, 2020 GNFR
FINAL REFUSAL WRITTEN
Apr 14, 2020 CNFR
TEAS/EMAIL CORRESPONDENCE ENTERED
Mar 24, 2020 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Mar 23, 2020 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Mar 23, 2020 TROA
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Mar 23, 2020 CHAN
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Mar 23, 2020 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Mar 23, 2020 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Mar 23, 2020 REAP
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Mar 23, 2020 COAR
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Jan 28, 2020 GNRN
NON-FINAL ACTION E-MAILED
Jan 28, 2020 GNRT
NON-FINAL ACTION WRITTEN
Jan 28, 2020 CNRT
ASSIGNED TO EXAMINER
Jan 23, 2020 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Oct 21, 2019 NWOS
NEW APPLICATION ENTERED
Oct 21, 2019 NWAP